Medical equipment maker Stereotaxis Inc. (NASDAQ:STXS) reported encouraging results from its recently completed first 50 clinical procedures performed using its new Niobe ES system for treating patients with complex cardiac arrhythmias (a disorder of the heart rhythm). The majority of these procedures were performed to treat atrial fibrillation, the most prevalent form of cardiac arrhythmia.
Results from these procedures, performed in Europe, showed that average time for completion of mapping and … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards